DocCheck AG is a Germany-based Company. The Company is engaged in the healthcare sector. The are three main business areas: agency business, access business and retail business. The agency business develops and implements communication concepts for the healthcare and B2B market. The access business helps to grow community for medical professionals. It also includes online advertising, online market research, online studies. The retail business provides medical supplies and medical technology.

Employees

414

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change
06/08/26	€11.20	0.00%
05/08/26	€11.20	-0.88%
04/08/26	€11.30	-1.74%
03/08/26	€11.50	+0.88%
31/07/26	€11.40	0.00%

Delayed Quote Deutsche Boerse AG

More quotes

Income Statement and Estimates

More financial data

Real-time Estimate Tradegate Other stock markets 21:44:11 06/08/2026 +04			5-day change	1st Jan Change
11.50 ^EUR	+2.68%		-1.75%	-8.20%

04-16	DocCheck AG announces Annual dividend, payable on June 02, 2026	CI
04-09	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	57.84M 66.65M 54.16M 49.54M 93.53M 6.35B 94.75M 634M 249M 3.17B 250M 245M 10.56B	P/E 2024	8.03x	P/E 2025	11.7x
Enterprise Value	40.25M 46.38M 37.69M 34.48M 65.09M 4.42B 65.94M 441M 173M 2.21B 174M 170M 7.35B	EV / Sales 2024	0.41x	EV / Sales 2025	0.81x
Free-Float	28.08%	Yield 2024	8.98%	Yield 2025	8.13%

04-16	DocCheck AG announces Annual dividend, payable on June 02, 2026	CI
04-09	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2025	CI
30/09/25	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2025	CI
15/04/25	DocCheck AG announces Annual dividend, payable on June 02, 2025	CI
10/04/25	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24/09/24	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2024	CI
11/04/24	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI
30/09/23	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2023	CI
14/04/23	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2022	CI
30/07/22	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2022	CI
14/04/22	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2021	CI
29/10/21	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2021	CI
16/04/21	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2020	CI

04-16	DocCheck : Information pursuant to Section 125 para. 2 German Stock Corporation Act (AktG) in connection with Section 125 para. 5 AktG, Article 4 para. 1 and Table 3 of the Annex to Implementing Regulation (EU) 2018/1212 (DocCheck Informationen nach 125 AktG und Tabelle 3 Blocke A bis F Durchfuhrungsverordnung EU 2018 1212 engl)	PU
15/04/25	DocCheck : Information pursuant to Section 125 para. 2 German Stock Corporation Act (AktG) in connection with Section 125 para. 5 AktG, Article 4 para. 1 and Table 3 of the Annex to Implementing Regulation (EU) 2018/1212 (2025 DocCheck Informationen nach 125 AktG englisch und Tabelle 3 Bloecke A to F)	PU
04/05/23	DD: DocCheck AG: Dr. Frank Antwerpes, buy	EQ
05/03/20	DocCheck AG : Notification and public disclosure of transactions by persons	EQ

DocCheck AG Stock Deutsche Boerse AG

Stocks

AJ91

DE000A1A6WE6

Healthcare Facilities & Services

Valuation: DocCheck AG

Chart: DocCheck AG

Latest news : DocCheck AG

Press Releases: DocCheck AG

News in other languages: DocCheck AG

Quotes and Performance

Course Extremes

Managers and Directors: DocCheck AG

Other Healthcare Facilities & Services

Financials

Company Profile

Quotes

Income Statement and Estimates

08-05	DocCheck Gruppe: Vorläufige Zahlen zum ersten Halbjahr 2026
05-28	DocCheck : Abstimmungsergebnisse (AJ91 Abstimmungsergebnisse HV2026)
05-28	DocCheck : Nachtrag (AJ91 1 Nachtrag)
05-25	Kalender der Dividendenausschüttungen und Hauptversammlungen vom 25. bis 29. Mai 2026
05-20	Vorläufige Zahlen zum ersten Quartal 2026

1 day	+2.68%
1 week	-1.75%
Current month	-1.75%
1 month	-1.75%
3 months	-23.29%
6 months	-11.11%
Current year	-8.20%

1 week	11	11.5
1 month	11	12.2
Current year	10.8	15.3
1 year	10.8	15.3
3 years	7	15.3
5 years	7	35.1
10 years	6.72	35.1

Manager	Title	Age	Since
Frank Nicolas Antwerpes CEO	Chief Executive Officer	65	-
Philip Stadtmann DFI	Director of Finance/CFO	-	01/08/2019
Jens Knoop CTO	Chief Tech/Sci/R&D Officer	-	01/08/2019

Director	Title	Age	Since
Joachim Pietzko CHM	Chairman	-	15/12/2014
Winfried Leimeister BRD	Director/Board Member	-	01/01/1999
Karin Immenroth BRD	Director/Board Member	-	31/03/2022

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DOCCHECK AG	+2.68%	-1.75%	-	-	66.78M
CVS HEALTH CORPORATION	-2.24%	-8.10%	+52.24%	+30.83%	127B
HCA HEALTHCARE, INC.	-0.47%	+2.93%	+11.26%	+49.45%	88.69B
FRESENIUS SE & CO. KGAA	+0.06%	+4.01%	+12.10%	+65.53%	30.34B
QUEST DIAGNOSTICS INCORPORATED	+0.63%	+1.18%	+37.03%	+73.53%	26.03B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-2.13%	-0.89%	-9.78%	-17.64%	22.32B
TENET HEALTHCARE CORPORATION	-0.81%	+2.74%	+63.04%	+243.00%	21.08B
FRESENIUS MEDICAL CARE AG	+1.38%	-5.44%	+3.36%	-10.93%	12.64B
DAVITA INC.	-4.35%	-24.33%	+41.41%	+60.40%	12.03B
MAX HEALTHCARE INSTITUTE LIMITED	-0.46%	-3.26%	-15.51%	+99.41%	11.05B
Average	-0.51%	-3.10%	+21.68%	+65.95%	38.99B
Weighted average by Cap.	-1.13%	-2.64%	+29.72%	+53.03%

	2024	2025
Net sales	53.79M 61.98M 50.36M 46.07M 86.97M 5.9B 88.11M 589M 231M 2.95B 233M 228M 9.82B	55.32M 63.74M 51.8M 47.38M 89.45M 6.07B 90.62M 606M 238M 3.03B 239M 234M 10.1B
Net income	5.28M 6.09M 4.95M 4.53M 8.54M 580M 8.66M 57.88M 22.71M 290M 22.86M 22.36M 964M	5.33M 6.15M 4.99M 4.57M 8.63M 586M 8.74M 58.43M 22.93M 293M 23.08M 22.58M 974M
Net Debt	-20.11M -23.17M -18.83M -17.22M -32.52M -2.21B -32.94M -220M -86.45M -1.1B -87M -85.11M -3.67B	-17.59M -20.27M -16.47M -15.07M -28.44M -1.93B -28.81M -193M -75.62M -965M -76.1M -74.45M -3.21B